PDB Short entry for 2OK1 HEADER TRANSFERASE 15-JAN-07 2OK1 TITLE CRYSTAL STRUCTURE OF JNK3 BOUND TO N-BENZYL-4-(4-(3-CHLOROPHENYL)-1H- TITLE 2 PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 10; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: STRESS-ACTIVATED PROTEIN KINASE JNK3, C-JUN N-TERMINAL COMPND 5 KINASE 3, MAP KINASE P49 3F12; COMPND 6 EC: 2.7.11.24; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK10, JNK3, JNK3A, PRKM10; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-15B KEYWDS KINASE INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR X.XIE,M.D.JACOBS REVDAT 5 27-DEC-23 2OK1 1 REMARK SEQADV REVDAT 4 18-OCT-17 2OK1 1 REMARK REVDAT 3 24-FEB-09 2OK1 1 VERSN REVDAT 2 27-MAR-07 2OK1 1 JRNL REVDAT 1 06-FEB-07 2OK1 0 JRNL AUTH A.M.ARONOV,C.BAKER,G.W.BEMIS,J.CAO,G.CHEN,P.J.FORD, JRNL AUTH 2 U.A.GERMANN,J.GREEN,M.R.HALE,M.JACOBS,J.W.JANETKA,F.MALTAIS, JRNL AUTH 3 G.MARTINEZ-BOTELLA,M.N.NAMCHUK,J.STRAUB,Q.TANG,X.XIE JRNL TITL FLIPPED OUT: STRUCTURE-GUIDED DESIGN OF SELECTIVE JRNL TITL 2 PYRAZOLYLPYRROLE ERK INHIBITORS. JRNL REF J.MED.CHEM. V. 50 1280 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17300186 JRNL DOI 10.1021/JM061381F REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 588524.062 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 15047 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.246 REMARK 3 R VALUE (WORKING SET) : 0.241 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1324 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.3570 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.3550 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.373 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 8.600 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1324 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 15364 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1918 REMARK 3 BIN R VALUE (WORKING SET) : 0.4750 REMARK 3 BIN FREE R VALUE : 0.4640 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 191 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.034 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2707 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 98 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 39.39000 REMARK 3 B22 (A**2) : -19.89000 REMARK 3 B33 (A**2) : -19.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM SIGMAA (A) : 0.76 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.84 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.570 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.340 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.350 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.730 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.670 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 33.90 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : INHIB.PAR REMARK 3 PARAMETER FILE 4 : PARMXRAY.XPL REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OK1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000041232. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17043 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 55.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.25200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18-20% (V/V) POLYETHYLENE GLYCOL REMARK 280 MONOMETHYL ETHER (AVERAGE MR =550), 10% (V/V) ETHYLENE GLYCOL, REMARK 280 20MM BME, 100MM HEPES, PH7.5), VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.12750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.74400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.16700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.74400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.12750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.16700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 38 REMARK 465 GLY A 39 REMARK 465 SER A 40 REMARK 465 LYS A 41 REMARK 465 SER A 42 REMARK 465 LYS A 43 REMARK 465 VAL A 44 REMARK 465 ASP A 45 REMARK 465 GLY A 71 REMARK 465 SER A 72 REMARK 465 ARG A 212 REMARK 465 THR A 213 REMARK 465 ALA A 214 REMARK 465 GLY A 215 REMARK 465 THR A 216 REMARK 465 SER A 217 REMARK 465 PHE A 218 REMARK 465 MET A 219 REMARK 465 MET A 220 REMARK 465 THR A 221 REMARK 465 PRO A 222 REMARK 465 TYR A 223 REMARK 465 VAL A 224 REMARK 465 GLN A 374 REMARK 465 ILE A 375 REMARK 465 TYR A 376 REMARK 465 ASP A 377 REMARK 465 LYS A 378 REMARK 465 GLN A 379 REMARK 465 LEU A 380 REMARK 465 SER A 401 REMARK 465 GLU A 402 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 66 82.32 14.08 REMARK 500 ALA A 74 -102.65 -110.19 REMARK 500 ARG A 97 53.72 38.79 REMARK 500 GLN A 140 -52.32 -146.15 REMARK 500 ARG A 188 -1.29 76.53 REMARK 500 ASP A 189 43.22 -143.08 REMARK 500 CYS A 201 1.13 82.39 REMARK 500 LYS A 241 -162.23 -116.60 REMARK 500 ARG A 301 167.86 -48.53 REMARK 500 ASP A 321 -75.32 -61.40 REMARK 500 SER A 322 -157.38 -123.12 REMARK 500 VAL A 368 -70.93 -105.84 REMARK 500 GLU A 382 99.64 67.27 REMARK 500 MET A 399 27.15 -79.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 33A A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OJG RELATED DB: PDB REMARK 900 RELATED ID: 2OJI RELATED DB: PDB REMARK 900 RELATED ID: 2OJJ RELATED DB: PDB DBREF 2OK1 A 40 402 UNP P53779 MK10_HUMAN 40 402 SEQADV 2OK1 MET A 38 UNP P53779 CLONING ARTIFACT SEQADV 2OK1 GLY A 39 UNP P53779 CLONING ARTIFACT SEQRES 1 A 365 MET GLY SER LYS SER LYS VAL ASP ASN GLN PHE TYR SER SEQRES 2 A 365 VAL GLU VAL GLY ASP SER THR PHE THR VAL LEU LYS ARG SEQRES 3 A 365 TYR GLN ASN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY SEQRES 4 A 365 ILE VAL CYS ALA ALA TYR ASP ALA VAL LEU ASP ARG ASN SEQRES 5 A 365 VAL ALA ILE LYS LYS LEU SER ARG PRO PHE GLN ASN GLN SEQRES 6 A 365 THR HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU MET SEQRES 7 A 365 LYS CYS VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN SEQRES 8 A 365 VAL PHE THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP SEQRES 9 A 365 VAL TYR LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS SEQRES 10 A 365 GLN VAL ILE GLN MET GLU LEU ASP HIS GLU ARG MET SER SEQRES 11 A 365 TYR LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU SEQRES 12 A 365 HIS SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER SEQRES 13 A 365 ASN ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU SEQRES 14 A 365 ASP PHE GLY LEU ALA ARG THR ALA GLY THR SER PHE MET SEQRES 15 A 365 MET THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO SEQRES 16 A 365 GLU VAL ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP SEQRES 17 A 365 ILE TRP SER VAL GLY CYS ILE MET GLY GLU MET VAL ARG SEQRES 18 A 365 HIS LYS ILE LEU PHE PRO GLY ARG ASP TYR ILE ASP GLN SEQRES 19 A 365 TRP ASN LYS VAL ILE GLU GLN LEU GLY THR PRO CYS PRO SEQRES 20 A 365 GLU PHE MET LYS LYS LEU GLN PRO THR VAL ARG ASN TYR SEQRES 21 A 365 VAL GLU ASN ARG PRO LYS TYR ALA GLY LEU THR PHE PRO SEQRES 22 A 365 LYS LEU PHE PRO ASP SER LEU PHE PRO ALA ASP SER GLU SEQRES 23 A 365 HIS ASN LYS LEU LYS ALA SER GLN ALA ARG ASP LEU LEU SEQRES 24 A 365 SER LYS MET LEU VAL ILE ASP PRO ALA LYS ARG ILE SER SEQRES 25 A 365 VAL ASP ASP ALA LEU GLN HIS PRO TYR ILE ASN VAL TRP SEQRES 26 A 365 TYR ASP PRO ALA GLU VAL GLU ALA PRO PRO PRO GLN ILE SEQRES 27 A 365 TYR ASP LYS GLN LEU ASP GLU ARG GLU HIS THR ILE GLU SEQRES 28 A 365 GLU TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASN SER SEQRES 29 A 365 GLU HET 33A A 1 27 HETNAM 33A N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H- HETNAM 2 33A PYRROLE-2-CARBOXAMIDE FORMUL 2 33A C21 H17 CL N4 O FORMUL 3 HOH *98(H2 O) HELIX 1 1 PRO A 98 GLN A 100 5 3 HELIX 2 2 ASN A 101 VAL A 118 1 18 HELIX 3 3 LEU A 153 GLN A 158 1 6 HELIX 4 4 ASP A 162 ALA A 183 1 22 HELIX 5 5 LYS A 191 SER A 193 5 3 HELIX 6 6 ALA A 231 LEU A 236 1 6 HELIX 7 7 ASN A 243 GLY A 254 1 12 HELIX 8 8 GLY A 254 HIS A 259 1 6 HELIX 9 9 ASP A 267 GLU A 277 1 11 HELIX 10 10 CYS A 283 LYS A 288 1 6 HELIX 11 11 GLN A 291 ASN A 300 1 10 HELIX 12 12 THR A 308 PHE A 313 1 6 HELIX 13 13 PRO A 314 PHE A 318 5 5 HELIX 14 14 SER A 322 LEU A 340 1 19 HELIX 15 15 SER A 349 GLN A 355 1 7 HELIX 16 16 ILE A 359 TYR A 363 5 5 HELIX 17 17 ASP A 364 GLU A 369 1 6 HELIX 18 18 THR A 386 MET A 399 1 14 SHEET 1 A 2 PHE A 48 VAL A 53 0 SHEET 2 A 2 SER A 56 LEU A 61 -1 O SER A 56 N VAL A 53 SHEET 1 B 5 TYR A 64 PRO A 69 0 SHEET 2 B 5 ILE A 77 ASP A 83 -1 O TYR A 82 N GLN A 65 SHEET 3 B 5 ARG A 88 SER A 96 -1 O LYS A 94 N ILE A 77 SHEET 4 B 5 ASP A 141 GLU A 147 -1 O MET A 146 N ALA A 91 SHEET 5 B 5 ASN A 128 PHE A 130 -1 N ASN A 128 O VAL A 145 SHEET 1 C 3 ALA A 151 ASN A 152 0 SHEET 2 C 3 ILE A 195 VAL A 197 -1 O VAL A 197 N ALA A 151 SHEET 3 C 3 LEU A 203 ILE A 205 -1 O LYS A 204 N VAL A 196 CISPEP 1 GLY A 73 ALA A 74 0 -4.84 SITE 1 AC1 11 PRO A 69 ILE A 70 ALA A 74 VAL A 78 SITE 2 AC1 11 ALA A 91 LYS A 93 GLU A 147 MET A 149 SITE 3 AC1 11 ASP A 150 VAL A 196 LEU A 206 CRYST1 52.255 70.334 107.488 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019137 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014218 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009303 0.00000